Amgen (AMGN) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
ROE, % ? 88.0% 179.0% 107.8% 69.6% 89.1%   84.9%  
Changes by years, y/y, % +11pp +91pp -71pp -38pp +19pp     +2.9%

Amgen. ROE, %

Amgen. ROE, changes, pp

Amgen (AMGN) ROE US GAAP (quarter values)

FY2025Q3 FY2025Q4 FY2026Q1 FY2026Q2 FY2026Q2   LTM ?
ROE, % ? 72.8% 89.1% 84.9% 74.8% 74.8%   84.9%
Changes by years, y/y, % +17pp +19pp -11pp -14pp -14pp    
Changes by quarters, q/q, % -16pp +16pp -4pp -10pp 0pp    

Amgen. ROE, %

Amgen. ROE, changes, pp

Amgen. ROE, changes, pp